Other papers submitted by: Professor Jonathan A Ledermann

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Professor Jonathan A Ledermann

Paper published by Professor Jonathan A Ledermann:

Review

Highly-accessed

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA

OncoTargets and Therapy 2022, 15:1105-1117

Published Date: 4 October 2022